# Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement

> **NCT00507962** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 51 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Liposomal Doxorubicin

## Key facts

- **NCT ID:** NCT00507962
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2012-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00507962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00507962, "Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00507962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*